Search results for ''
Investors
OrbiMed
OrbiMed is a leading investment firm dedicated exclusively to the healthcare sector, with over $14 billion in assets under management. OrbiMed invests globally across the spectrum of healthcare companies, from venture capital start-ups to large multinational corporations, utilizing a range of private equity funds, public equity funds, royalty/debt funds and other investment vehicles. OrbiMed maintains its headquarters in New York City, with additional offices in San Francisco, Shanghai, Hong Kong,
Legal Information
Site Editor
ENYO Pharma SA
BIOSERRA 1 Bâtiment B
60 avenue Rockefeller
69008 LYON, FRANCE
+33 (0)4 37 70 02 19
Email:
SIREN: 799 831 011 RCS Lyon
Publishing Director: Jacky Vonderscher, CEO
Hosting
Hosting is provided by iilyo SAS
Address: 33, place bellecour, 69002 Lyon, FRANCE
No warranty and no liability
While ENYO Pharma SA is making best efforts to include accurate and up-to-date information,
Contact us
Office
ENYO Pharma SA
BIOSERRA 1 Bâtiment B
60 avenue Rockefeller
69008 LYON, FRANCE
For general information, please call +33 (0)4 37 70 02 19 or email
Clinical trials
- If you are a patient and interested in participating in a clinical trial of ENYO Pharma, please visit www.enyopharma.com/patients and www.clinicaltrials.gov/ENYO Pharma.
We encourage to speak with your physician about the eligibility criteria.
Latest Press Release 